AR062711A1 - Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad - Google Patents

Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad

Info

Publication number
AR062711A1
AR062711A1 ARP070103969A ARP070103969A AR062711A1 AR 062711 A1 AR062711 A1 AR 062711A1 AR P070103969 A ARP070103969 A AR P070103969A AR P070103969 A ARP070103969 A AR P070103969A AR 062711 A1 AR062711 A1 AR 062711A1
Authority
AR
Argentina
Prior art keywords
proteins
purification
affinity chromatography
arginine
product
Prior art date
Application number
ARP070103969A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39158086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR062711(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR062711A1 publication Critical patent/AR062711A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

La presente se refiere a métodos para aislar un producto y/o reducir la turbidez y/o impurezas de un fluido de carga que comprende el producto y una o más impurezas al pasar el fluido de carga a través de un medio, seguido por al menos una solucion de lavado que comprende arginina o un derivado de arginina, y recolectar el producto al usar una solucion de elucion. La presente se refiere además a un producto preparado al usar un método corno se describe en la presente.
ARP070103969A 2006-09-08 2007-09-07 Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad AR062711A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84308406P 2006-09-08 2006-09-08

Publications (1)

Publication Number Publication Date
AR062711A1 true AR062711A1 (es) 2008-11-26

Family

ID=39158086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103969A AR062711A1 (es) 2006-09-08 2007-09-07 Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad

Country Status (17)

Country Link
US (2) US7714111B2 (es)
EP (1) EP2059258B1 (es)
JP (1) JP5386354B2 (es)
KR (1) KR20090064377A (es)
CN (1) CN101511387A (es)
AR (1) AR062711A1 (es)
AU (1) AU2007292253A1 (es)
BR (1) BRPI0716597A2 (es)
CA (1) CA2661645C (es)
CL (1) CL2007002615A1 (es)
ES (1) ES2764222T3 (es)
IL (1) IL197053A0 (es)
MX (1) MX2009002576A (es)
PE (1) PE20080913A1 (es)
RU (1) RU2009106083A (es)
TW (1) TW200821026A (es)
WO (1) WO2008031020A2 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2655873C (en) * 2006-07-14 2017-10-17 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
SG10201510384UA (en) 2006-09-13 2016-01-28 Abbvie Inc Cell culture improvements
DK2089429T3 (en) * 2006-10-19 2015-01-12 Janssen Biotech Inc PROCEDURE FOR MANUFACTURING NON-AGGREGATED ANTIBODY-FC DOMAINS
US8669045B2 (en) * 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
MX2011004200A (es) * 2008-10-20 2011-05-24 Abbott Lab Aislamento y purificacion de anticuerpos usando la cromatografia de afinidad de proteina a.
WO2010048192A2 (en) 2008-10-20 2010-04-29 Abbott Laboratories Viral inactivation during purification of antibodies
DK2350271T3 (en) 2008-11-20 2016-04-04 Biogen Ma Inc ARGININ INACTIVATION OF ENVIRONMENT VIRA
EP2406274A2 (en) 2009-03-11 2012-01-18 Wyeth LLC Methods of purifying small modular immunopharmaceutical proteins
EP4328305A3 (en) 2009-12-18 2024-08-14 CSL Ltd. Method of purifying polypeptides
SG10201408384PA (en) * 2009-12-18 2015-01-29 Novartis Ag Wash solution and method for affinity chromatography
ES2492681T3 (es) * 2010-01-22 2014-09-10 Boehringer Ingelheim International Gmbh Método cromatográfico para purificar proteínas que contienen FC
WO2011162210A1 (ja) * 2010-06-21 2011-12-29 協和発酵キリン株式会社 アミノ酸を利用したタンパク質の精製方法
EP3428176A1 (en) 2011-06-01 2019-01-16 Novartis AG Wash solution and method for affinity chromatography
WO2013055958A1 (en) 2011-10-11 2013-04-18 Genentech, Inc. Improved assembly of bispecific antibodies
US20130109807A1 (en) * 2011-10-26 2013-05-02 Bio-Rad Laboratories, Inc. Removal of virucidal agents in mixed mode chromatography
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
KR101414897B1 (ko) * 2013-11-29 2014-07-04 씨제이헬스케어 주식회사 다베포에틴 알파의 정제 방법
CA2962105A1 (en) 2014-09-24 2016-03-31 Basf Se Method for producing diesters of terephthalic acid
EP3197858B1 (de) 2014-09-24 2019-02-06 Basf Se Verfahren zur herstellung von terephthalsäurediestern mit umwälzung des reaktionsgemisches
BR112017005850A2 (pt) 2014-09-24 2018-02-06 Basf Se processo e aparelho para preparação de um diéster tereftálico.
CN106715382A (zh) 2014-09-24 2017-05-24 巴斯夫欧洲公司 通过再循环醇脱水而制备对苯二甲酸二酯的方法
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
EP3268100A1 (en) 2015-03-13 2018-01-17 Bristol-Myers Squibb Company Use of alkaline washes during chromatography to remove impurities
HRP20160086A2 (hr) 2016-01-27 2017-08-11 Sveučilište u Zagrebu Eluens za imunoafinitetnu kromatografiju virusa i proteina
DE102016106271B4 (de) 2016-04-06 2018-03-29 Axagarius Gmbh & Co. Kg Aufreinigung von Nukleinsäure aus einer Nukleinsäure und Endotoxin enthaltenden Probe
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
JP7106187B2 (ja) 2016-05-11 2022-07-26 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックスを保存する方法
CN109311948B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 清洁和/或消毒分离基质的方法
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
EP3455243B1 (en) 2016-05-11 2021-03-24 Cytiva BioProcess R&D AB Separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
KR102359192B1 (ko) * 2016-07-25 2022-02-04 세파론, 인코포레이티드 친화성 크로마토그래피 세정 완충액
JP7058272B2 (ja) * 2016-09-07 2022-04-21 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド 抗体を精製するための方法
AU2018212974B2 (en) * 2017-01-30 2023-08-24 Regeneron Pharmaceuticals, Inc. Compositions and methods for reducing bioburden in chromatography
TW202000891A (zh) * 2018-03-07 2020-01-01 英商葛蘭素史克智慧財產發展有限公司 純化抗體之方法
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
CN108586606A (zh) * 2018-04-24 2018-09-28 上海药明生物技术有限公司 一种用于去除抗体蛋白中内毒素的方法
US20230143163A1 (en) * 2020-04-27 2023-05-11 Alexion Pharmaceuticals, Inc. Protein a chromatography purification of an antibody
US20230166201A1 (en) * 2020-05-01 2023-06-01 Kashiv Biosciences, Llc An improved process of affinity chromatography
CN113980092B (zh) * 2021-12-09 2024-05-14 上海药明生物技术有限公司 一种蛋白质亲和纯化方法
CN114891061A (zh) * 2022-04-25 2022-08-12 杭州艾策生物技术有限公司 一种糖基化重组蛋白的纯化方法
TW202423945A (zh) * 2022-12-12 2024-06-16 丹麥商H 朗德貝克公司 蛋白質純化中的精胺酸洗滌

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010148A (en) 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤
US4230697A (en) * 1978-07-03 1980-10-28 Morinaga Milk Industry Co. Ltd. Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
US4624932A (en) 1978-09-13 1986-11-25 Samuel Bogoch Recognins and their chemoreciprocals
EP0009781B2 (en) 1978-09-29 1986-04-23 Mitsubishi Kasei Corporation Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby
JPS5569595A (en) 1978-11-20 1980-05-26 Suguru Abe Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation
CA1172980A (en) 1979-04-02 1984-08-21 Kenji Takemoto Pentadecapeptide and process for the preparation thereof
DE3034529C2 (de) 1980-09-12 1982-09-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel
DE3110561A1 (de) 1981-03-18 1982-11-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Chemorekrutine der leukozyten und des entszuendungsgewebes: eine neue klasse natuerlicher leukopoetine zurselektiven chemorekrutierung von leukozyten aus dem knochenmark in den blutstrom (leukozytose- und linskverschiebungsreaktion)
DE3110560A1 (de) * 1981-03-18 1982-10-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
US4532207A (en) 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
US4390468A (en) 1982-08-04 1983-06-28 Maruzen Oil Co., Ltd. Preparation of antitumor agent from shellfish
US4882421A (en) 1982-09-23 1989-11-21 Alfacell Corporation Pharmaceutical for treating tumors and method for making it
US4568545A (en) * 1982-10-02 1986-02-04 Amano Seiyaku Kabushiki Kaisha Thrombolytic agent
JPS5980613A (ja) 1982-10-29 1984-05-10 Mitsui Toatsu Chem Inc 新規なプラスミノ−ゲン・アクチベ−タ及びその製造方法
US4880914A (en) 1982-11-09 1989-11-14 Cornell Research Foundation, Inc. Assay for qualitatively and/or quantitatively measuring hLH or hCG in body fluids and reagents therefor
US4966888A (en) 1985-07-08 1990-10-30 Cornell Research Foundation, Inc. hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
GB8314362D0 (en) 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
US4456676A (en) 1983-06-10 1984-06-26 E. I. Du Pont De Nemours And Company Amine stabilizers for wash-off systems
US4444760A (en) * 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
JPS60184098A (ja) * 1984-03-02 1985-09-19 Suntory Ltd 新規なペプチド及びこれを有効成分とする利尿剤
JPH0794473B2 (ja) 1984-03-02 1995-10-11 サントリー株式会社 新規なペプチド及びこれを有効成分とする利尿剤
US4670539A (en) 1984-07-27 1987-06-02 Board Of Regents, The University Of Texas Peptide growth factors derived from estrogen responsive kidney tissue
US5132214A (en) 1986-04-09 1992-07-21 Monsanto Company Large scale production of plasminogen activator from normal human colon cells
US5030559A (en) 1986-04-01 1991-07-09 Board Of Regents, The University Of Texas System Methods and compositions for the identification of metastatic human tumors
US5213970A (en) 1987-01-23 1993-05-25 Board Of Regents, The University Of Texas System Method for obtaining soluble antitumor factor
US5162507A (en) 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
JPH01238534A (ja) * 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5760183A (en) 1989-02-17 1998-06-02 Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
DE3914354C1 (es) 1989-04-29 1990-10-31 Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
FR2676231A1 (fr) * 1991-05-07 1992-11-13 Aetsrn Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
JPH0518950A (ja) 1991-07-09 1993-01-26 Showa Denko Kk アフイニテイクロマトグラフイー用吸着担体
DE59208181D1 (de) 1991-12-18 1997-04-17 Hoechst Ag Verfahren zur Gewinnung von insulinhaltigen Lösungen
US5372942A (en) 1992-02-10 1994-12-13 Coriell Institute For Medical Research Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
JP2767521B2 (ja) 1992-09-04 1998-06-18 農林水産省食品総合研究所長 新規抗腫瘍性蛋白質とその製造法および該蛋白質を有効成分として含有する抗腫瘍剤
JP3801196B2 (ja) 1993-03-09 2006-07-26 ジェンザイム・コーポレイション 乳からの対象化合物の単離
US5710126A (en) * 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US6607884B1 (en) 1993-03-19 2003-08-19 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-8
US5332503A (en) 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5330972A (en) 1993-05-28 1994-07-19 Abbott Laboratories Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
JP2971293B2 (ja) 1993-06-11 1999-11-02 株式会社細菌化学研究所 溶血性連鎖球菌の産生する生理活性物質及びその製造法
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5478924A (en) 1994-02-16 1995-12-26 Cramer; Steven M. Displacement chromatography of proteins using low molecular weight displacers
US5570389A (en) 1994-06-30 1996-10-29 Compaq Computer Corporation Method for reliable exchange of modem handshaking information over a cellular radio carrier
US5659017A (en) 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
DE19600939C1 (de) * 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
SE9603068D0 (sv) 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
SI0950067T1 (sl) * 1996-11-27 2007-12-31 Genentech Inc Afinitetno čiščenje polipeptida na proteinskemA matriksu
ZA9711580B (en) 1996-12-25 1999-09-23 Hoechst Marion Roussel Ltd Process for the production of purified dimeric bone morphogenetic factors.
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
US6451260B1 (en) * 1997-08-26 2002-09-17 Dyax Corp. Method for producing microporous elements, the microporous elements thus produced and uses thereof
US20030036629A1 (en) * 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
US6673629B2 (en) * 1998-01-15 2004-01-06 Abbott Laboratories Neutralization of polycations in a chromatographic device for whole blood use
DE19937219A1 (de) 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie
AU3959499A (en) 1998-05-28 1999-12-13 Korea Green Cross Corporation Process of purifying angiogenesis inhibitors
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
GB9815666D0 (en) 1998-07-17 1998-09-16 Smithkline Beecham Plc Novel compounds
RU2143492C1 (ru) 1998-07-23 1999-12-27 Навашин Петр Сергеевич Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
RU2144082C1 (ru) 1998-07-23 2000-01-10 Навашин Петр Сергеевич Рекомбинантная плазмида, кодирующая гибридный белок-предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка-предшественника инсулина человека (варианты) и способ получения инсулина человека
US7198896B2 (en) 1998-09-04 2007-04-03 Cell Signaling Technology, Inc. Immunoaffinity isolation of modified peptides from complex mixtures
US7300753B2 (en) * 1998-09-04 2007-11-27 John Rush Immunoaffinity isolation of modified peptides from complex mixtures
US7307161B1 (en) 1999-04-28 2007-12-11 Genetics Institute, Llc Human Gil-19/AE289 polynucleotides
US6939545B2 (en) 1999-04-28 2005-09-06 Genetics Institute, Llc Composition and method for treating inflammatory disorders
DE19937218A1 (de) 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
US6774102B1 (en) * 1999-09-29 2004-08-10 Gambro Dialysatoren Gmbh & Co. Kg Extracorporeal endotoxin removal method
PT1226269E (pt) 1999-11-04 2003-11-28 Genentech Inc Ensaio de hplc de fase reversa para activadores de plasminogenio
US6825164B1 (en) * 2000-08-14 2004-11-30 The Trustees Of Columbia University In The City Of New York Method to increase cerebral blood flow in amyloid angiopathy
DE10046960A1 (de) 2000-09-22 2002-04-11 Roche Diagnostics Gmbh Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen
US7829084B2 (en) * 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
US7638604B2 (en) * 2001-02-23 2009-12-29 Genetics Institute, Llc Monoclonal antibodies against interleukin-22
US20040058445A1 (en) * 2001-04-26 2004-03-25 Ledbetter Jeffrey Alan Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB
CA2448788C (en) * 2001-06-05 2010-08-24 Genetics Institute, Llc. Methods for purifying highly anionic proteins
AU2002327795A1 (en) 2001-10-09 2003-04-22 The Government Of The United States Of America, As Represented By The Department Of Health And Human Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
US20040161776A1 (en) * 2001-10-23 2004-08-19 Maddon Paul J. PSMA formulations and uses thereof
AU2003212912A1 (en) * 2002-02-04 2003-09-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
AU2003210802B2 (en) 2002-02-05 2009-09-10 Genentech Inc. Protein purification
WO2004000220A2 (en) 2002-06-21 2003-12-31 Genetix Pharmaceuticals, Inc. Methods for purifying viral particles for gene therapy
AR047392A1 (es) * 2002-10-22 2006-01-18 Wyeth Corp Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
DK1678208T3 (da) * 2003-10-27 2013-07-08 Wyeth Llc Fjernelse af aggregater med høj molekylvægt under anvendelse af hydroxyapatitchromatografi
US7065110B2 (en) * 2004-01-20 2006-06-20 Northrop Grumman Corporation Scalable wavelength shifted laser source and method
US8084032B2 (en) * 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
US7501121B2 (en) * 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
ES2797480T3 (es) * 2005-03-11 2020-12-02 Wyeth Llc Un procedimiento de cromatografía de reparto débil

Also Published As

Publication number Publication date
MX2009002576A (es) 2009-03-20
US20080064861A1 (en) 2008-03-13
ES2764222T3 (es) 2020-06-02
RU2009106083A (ru) 2010-10-20
JP2010502737A (ja) 2010-01-28
IL197053A0 (en) 2009-11-18
PE20080913A1 (es) 2008-08-21
CA2661645C (en) 2016-11-08
EP2059258A4 (en) 2012-05-02
EP2059258A2 (en) 2009-05-20
KR20090064377A (ko) 2009-06-18
CN101511387A (zh) 2009-08-19
TW200821026A (en) 2008-05-16
US7714111B2 (en) 2010-05-11
WO2008031020A2 (en) 2008-03-13
US8350013B2 (en) 2013-01-08
WO2008031020A3 (en) 2008-10-23
EP2059258B1 (en) 2019-11-13
CA2661645A1 (en) 2008-03-13
AU2007292253A1 (en) 2008-03-13
BRPI0716597A2 (pt) 2013-10-08
CL2007002615A1 (es) 2008-04-18
US20080064860A1 (en) 2008-03-13
JP5386354B2 (ja) 2014-01-15

Similar Documents

Publication Publication Date Title
AR062711A1 (es) Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad
AR062570A1 (es) Proceso para la purificacion de las proteinas que contienen fc
AR069097A1 (es) Purificacion de anticuerpos por cromatografia de intercambio cationico
UY31789A1 (es) Composiciones de insulina de super rápida actuación
WO2007109163A3 (en) Wash buffer and method of using
MX2012007103A (es) Solucion y metodo de lavado por cromatografia de afinidad.
AR086525A1 (es) Metodo de purificacion de anticuerpos
AR063587A1 (es) Preparcion liquida que comprende pimobendan
MEP44608A (en) Methods for treating infectious disease exacerbated asthma
SG149759A1 (en) Media for affinity chromatography
SG10201908027QA (en) Use of alkaline washes during chromatography to remove impurities
SG194460A1 (en) Wash solution and method for affinity chromatography
WO2009123764A3 (en) Compositions and use of epas1 inhibitors
NZ590257A (en) Method of preparing alpha-1 proteinase inhibitor
TR201911082T4 (tr) K vitaminine bağımlı proteinlerin saflaştırılması için bir işlem.
ES2674177T3 (es) Preparación de suero
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
BR112014000522A2 (pt) meio de cultura, método para cultivar salmonella e e. coli e método para detectar salmonella e e. coli
CL2007003659A1 (es) Kit de deteccion de microorganismos patogenos mediante pruebas de aliento.
MY157846A (en) Process for the purification of fc-containing proteins
EA200970074A1 (ru) Химический способ создания давления
MX2013013224A (es) Procedimiento de purificacion de proteinas de bajo ph.
MX2014003415A (es) Mediadores azo.
FR3024142B1 (fr) Procede de purification de glycol utilise comme agent anti-hydrate
FR2936438B1 (fr) Dispositif d'usinage destine au polissage de chants, permettant une automatisation complete de l'operation

Legal Events

Date Code Title Description
FB Suspension of granting procedure